Subtype
Cervical Neuroendocrine Neoplasm
CI-CAN-00000666Explore in graph →
Non-malignant2 active trials
- NCIt
- C128041
Loading cancer entity…
Subtype
CI-CAN-00000666Explore in graph →
Clinical trials
13 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04635956 | Camrelizumab Combined With Chemotherapy for Recurrent or Advanced Cervical Neuroendocrine Carcinomas | unknown | Phase 2 | 20 | Lei LiOTHER | 1 | Nov 19, 2020 | clinicaltrials |
Data updated 22 days agoSource updated Nov 19, 2020source: clinicaltrials